
    
      Population : Patients aged 18 years and older with an epithelial ovarian cancer, fallopian
      tube or primary peritoneal with platinum-sensitive recurrent witch it was decided to initiate
      a treatment with trabectedin (Yondelis®)-Pegylated liposomal doxorubicin(Caelyx)®.
    
  